Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This phase I/II trial studied the side effects and best dose of clofarabine when given
together with cytarabine and to see how well they work in treating older patients with acute
myeloid leukemia (AML) or high-risk myelodysplastic syndromes (MDS) that have relapsed or not
responded to treatment.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Fred Hutchinson Cancer Research Center Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium